{"id":2345,"date":"2013-12-31T00:00:47","date_gmt":"2013-12-30T17:00:47","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=2345"},"modified":"2013-12-31T00:00:47","modified_gmt":"2013-12-30T17:00:47","slug":"pharmacokinetics-of-low-dose-raltegravir","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/studies\/2345\/","title":{"rendered":"Pharmacokinetics of low dose Raltegravir"},"content":{"rendered":"\n\t\t\t\t\n<p class=\"wp-block-paragraph\"><strong>Project no.:<\/strong> HIV-NAT 127\/Raltegravir study<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This study will compare the pharmacokinetics of raltegravir at 400 mg daily and 800 mg daily versus the standard 400 mg raltegravir taken twice daily among HIV-infected patients on ART and have HIV viral load less than 50 copies\/ml.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Publications:<\/strong> Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapy. Antimicrob Agents Chemother. 2012 Apr;56(4):1892-8. doi: 10.1128\/AAC.05694-11.\u00a0 <\/p>\n\t\t","protected":false},"excerpt":{"rendered":"<p>\t\t\t\tThis study will compare the pharmacokinetics of raltegravir at 400 mg daily and 800 mg daily versus the standard 400 mg raltegravir taken twice daily among HIV-infected patients on ART and have HIV viral load less than 50 copies\/ml.\t\t<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-2345","post","type-post","status-publish","format-standard","hentry","category-studies"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=2345"}],"version-history":[{"count":0,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2345\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=2345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=2345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=2345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}